Study to Evaluate the Safety and Efficacy of the Renal Assist Device in Patients With Acute Renal Failure

Stopped early · Phase 2

Conditions studied: Kidney Failure, Acute

In brief

* The purpose of this study is to evaluate the safety and efficacy of the RAD to determine whether the RAD is effective in reducing mortality in patients with Acute Renal Failure due to Acute Tubule Necrosis and to evaluate the safety of the RAD * If the RAD works normally when used for as long as 72 hours * If the RAD will provide added benefits to normal CVVH therapy for patients with Acute Renal Failure

Key facts

Study ID
NCT00280072
Run by
RenaMed Biologics
Starts
2006-01-01
Expected to finish
2007-08-01
Last updated by the study team
2012-12-03

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.